Beryl Drugs Limited (BOM:524606)
20.35
+1.73 (9.29%)
At close: Mar 10, 2026
Beryl Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 103 | 107 | 149 | 62 | 53 | 34 | Upgrade
|
| Market Cap Growth | -38.63% | -28.23% | 141.20% | 16.36% | 58.09% | 81.10% | Upgrade
|
| Enterprise Value | 146 | 150 | 194 | 106 | 85 | 72 | Upgrade
|
| Last Close Price | 20.35 | 21.05 | 29.33 | 12.16 | 10.45 | 6.61 | Upgrade
|
| PE Ratio | 731.98 | 18.45 | 19.35 | 8.05 | - | 13.99 | Upgrade
|
| PS Ratio | 0.58 | 0.51 | 0.56 | 0.23 | 0.36 | 0.24 | Upgrade
|
| PB Ratio | 1.09 | 1.12 | 1.67 | 0.77 | 0.73 | 0.42 | Upgrade
|
| P/TBV Ratio | 1.09 | 1.12 | 1.67 | 0.77 | 0.73 | 0.42 | Upgrade
|
| P/FCF Ratio | - | 23.65 | - | 7.45 | - | - | Upgrade
|
| P/OCF Ratio | - | 4.05 | 18.14 | 2.58 | - | 9.90 | Upgrade
|
| EV/Sales Ratio | 0.82 | 0.71 | 0.73 | 0.40 | 0.58 | 0.51 | Upgrade
|
| EV/EBITDA Ratio | 10.13 | 5.73 | 7.34 | 4.77 | 15.35 | 4.43 | Upgrade
|
| EV/EBIT Ratio | 92.30 | 10.91 | 13.43 | 7.52 | - | 20.77 | Upgrade
|
| EV/FCF Ratio | - | 33.29 | - | 12.81 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.45 | 0.43 | 0.57 | 0.56 | 0.73 | 0.65 | Upgrade
|
| Debt / EBITDA Ratio | 2.99 | 1.56 | 1.93 | 2.04 | 9.60 | 3.17 | Upgrade
|
| Debt / FCF Ratio | - | 9.08 | - | 5.49 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.45 | 0.35 | 0.56 | 0.49 | 0.63 | 0.56 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.95 | 1.25 | 1.88 | 1.78 | 8.38 | 2.76 | Upgrade
|
| Net Debt / FCF Ratio | - | 7.28 | -9.35 | 4.80 | -5.23 | -3.35 | Upgrade
|
| Asset Turnover | - | 1.26 | 1.53 | 1.52 | 0.80 | 0.79 | Upgrade
|
| Inventory Turnover | - | 5.73 | 9.72 | 7.24 | 3.27 | 4.44 | Upgrade
|
| Quick Ratio | - | 1.47 | 1.34 | 1.25 | 0.79 | 0.85 | Upgrade
|
| Current Ratio | - | 2.10 | 1.76 | 1.64 | 1.24 | 1.24 | Upgrade
|
| Return on Equity (ROE) | - | 6.28% | 9.05% | 9.97% | -8.66% | 3.08% | Upgrade
|
| Return on Assets (ROA) | - | 5.15% | 5.16% | 4.99% | -1.83% | 1.21% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.15% | 6.90% | 8.48% | 9.17% | -4.40% | 1.92% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 11.80% | 12.30% | 12.60% | -5.70% | 3.30% | Upgrade
|
| Earnings Yield | 0.14% | 5.42% | 5.17% | 12.42% | -12.43% | 7.15% | Upgrade
|
| FCF Yield | - | 4.23% | -3.57% | 13.42% | -16.68% | -39.77% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | - | - | - | 0.01% | -0.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.